Protein kinase Cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor - Induced permeability in vivo

Diabetes

Volumn 61, Issue 6, 2012, Pages 1573-1583

  Murakami, Tomoaki ^a   Frey, Tiffany ^a   Lin, Chengmao ^a   Antonetti, David A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCCLUDIN; PROTEASOME; PROTEIN KINASE C BETA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CONFOCAL MICROSCOPY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TIGHT JUNCTION; UBIQUITINATION;

ANIMALS; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; CATTLE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; MALE; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RETINA; TIGHT JUNCTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861918691     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1367     Document Type: Article

References (45)

1. Antonetti DA, Barber AJ, Bronson SK, et al.; JDRF Diabetic Retinopathy Center Group. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006;55:2401-2411 (Pubitemid 44871140)
2. Harhaj NS, Antonetti DA. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 2004;36:1206-1237 (Pubitemid 38519069)
3. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480-1487 (Pubitemid 24356306)
4. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816 (Pubitemid 40051904)
5. Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077
6. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 2006;47:5106-5115 (Pubitemid 46586418)
7. Davis MD, Sheetz MJ, Aiello LP, et al.; PKC-DRS2 Study Group. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema. Invest Ophthalmol Vis Sci 2009;50:1-4
8. Aiello LP, Davis MD, Girach A, et al.; PKC-DRS2 Group. Effect of rubox-istaurin on visual loss in patients with diabetic retinopathy. Ophthalmology 2006;113:2221-2230
9. Aiello LP, Vignati L, Sheetz MJ, et al. Oral protein kinase c beta inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study and the Protein kinase C beta Inhibitor-Diabetic Retinopathy Study 2. Retina 2011;31:2084-2094
10. Suzuma K, Takahara N, Suzuma I, et al. Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci USA 2002;99:721-726 (Pubitemid 34106577)
11. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor. Diabetes 1997;46:1473-1480 (Pubitemid 27369086)
12. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-293 (Pubitemid 33676971)
13. Bauer HC, Traweger A, Zweimueller-Mayer J, et al. New aspects of the molecular constituents of tissue barriers. J Neural Transm 2011;118:7-21
14. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003;161:653-660 (Pubitemid 36578587)
15. Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000;11:4131-4142
16. Jain S, Suzuki T, Seth A, et al. PKCzeta phosphorylates occludin and promotes assembly of epithelial tight junctions. Biochem J 2011;437:289-299
17. Suzuki T, Elias BC, Seth A, et al. PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proc Natl Acad Sci USA 2009;106:61-66
18. Elias BC, Suzuki T, Seth A, et al. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem 2009;284:1559-1569
19. Raleigh DR, Boe DM, Yu D, et al. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol 2011;193:565-582
20. Yamamoto M, Ramirez SH, Sato S, et al. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am J Pathol 2008;172:521-533 (Pubitemid 351282037)
21. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 1999;274:23463-23467
22. Barber AJ, Antonetti DA, Gardner TW; The Penn State Retina Research Group. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000;41:3561-3568
23. Sundstrom JM, Tash BR, Murakami T, et al. Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J Proteome Res 2009;8:808-817
24. Di Fiore PP, Polo S, Hofmann K. When ubiquitin meets ubiquitin receptors: a signalling connection. Nat Rev Mol Cell Biol 2003;4:491-497 (Pubitemid 36648594)
25. Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem 2009;284:21036-21046
26. Duval M, Bédard-Goulet S, Delisle C, Gratton JP. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cblmediated ubiquitination. Consequences on nitric oxide production from endothelial cells. J Biol Chem 2003;278:20091-20097 (Pubitemid 36799203)
27. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 2008;49:2635-2642
28. Phillips BE, Cancel L, Tarbell JM, Antonetti DA. Occludin independently regulates permeability under hydrostatic pressure and cell division in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2008;49:2568-2576
29. Chalfant CE, Ohno S, Konno Y, et al. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol 1996;10:1273-1281 (Pubitemid 26330959)
30. Antonetti DA, Wolpert EB. Isolation and characterization of retinal endothelial cells. In The Blood-Brain Barrier: Biology and Research Protocols. Nag S, Ed. Totowa, New Jersey, Humana Press, 2003, p. 365-374
31. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001;42:789-794 (Pubitemid 32206923)
32. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994;267:L223-L241
33. Scott IU, Edwards AR, Beck RW, et al.; Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-1867
34. Steinberg SF. Structural basis of protein kinase C isoform function. Physiol Rev 2008;88:1341-1378
35. Kaneto H, Nakatani Y, Miyatsuka T, et al. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat Med 2004;10:1128-1132 (Pubitemid 39424876)
36. Gao M, Labuda T, Xia Y, et al. Jun turnover is controlled through JNKdependent phosphorylation of the E3 ligase Itch. Science 2004;306:271-275 (Pubitemid 39336871)
37. Marchiando AM, Shen L, Graham WV, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 2010;189:111-126
38. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989; 169:1977-1991 (Pubitemid 19162960)
39. Takahashi S, Iwamoto N, Sasaki H, et al. The E3 ubiquitin ligase LNX1p80 promotes the removal of claudins from tight junctions in MDCK cells. J Cell Sci 2009;122:985-994
40. Nishimura N, Sasaki T. Rab family small G proteins in regulation of epithelial apical junctions. Front Biosci 2009;14:2115-2129
41. Morimoto S, Nishimura N, Terai T, et al. Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J Biol Chem 2005;280:2220-2228
42. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006;312:549-560 (Pubitemid 43290332)
43. Scheppke L, Aguilar E, Gariano RF, et al. Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest 2008;118:2337-2346 (Pubitemid 351872350)
44. Walter JK, Castro V, Voss M, et al. Redox-sensitivity of the dimerization of occludin. Cell Mol Life Sci 2009;66:3655-3662
45. Walter JK, Rueckert C, Voss M, et al. The oligomerization of the coiled coildomain of occludin is redox sensitive. Ann N Y Acad Sci 2009;1165:19-27